Preclinical studies showed lipolytic and anti-lipogenic effects, but human trials failed to demonstrate significant weight-loss outcomes
Having everything clean, sterile, and within arm's reach is the first step toward a smooth and successful process
Available in packs of 6, the sharp, beveled, curved, non-coring needle tip is perfect for septum piercing and is also recommended for manual GC injection, ensuring precise and efficient fluid transfer

(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement
Whether you are just beginning or have been trying various methods without success, our clinic offers a range of effective weight loss treatments tailored to your individual needs
What is encouraging, however, when thinking about the impact vaccination could have, is the apparent eradication of influenza A subtypes from the human population linked to cross-reactive immunity